echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > National Medical Insurance Administration: To launch a pilot program for direct settlement of outpatient chronic diseases related treatment costs across provinces

    National Medical Insurance Administration: To launch a pilot program for direct settlement of outpatient chronic diseases related treatment costs across provinces

    • Last Update: 2021-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Xinhua News Agency, Beijing, September 15 (Reporter Peng Yunjia) In order to further solve the "difficult and sorrowful" problem encountered by the people in trans-provincial treatment and settlement, the National Medical Insurance Bureau has made it clear that by the end of 2021, each province (autonomous region, municipality) and Xinjiang production and construction Corps select at least one co-ordinating carry out inter-provincial direct treatment costs related to clearing pilot outpatient slow special disease, we can offer high blood pressure , diabetes, malignant tumor outpatient chemotherapy, uremia, dialysis, organ transplantation anti-rejection therapy after five The treatment costs related to chronic diseases in outpatient clinics are directly settled across provinces
    .
     
    According to the "Notice on Implementing the Pilot Work for Direct Settlement of Outpatient Chronic and Special Diseases Related Treatment Expenses" issued by the National Medical Insurance Administration and the Ministry of Finance, the pilot population has completed the above five outpatient chronic and special disease treatment qualification certifications in the insured area.
    And in accordance with the regulations of the place of insured, the personnel who have gone through the procedures for medical records in different places across provinces
    .
     
    In order to be compatible with the differences in the scope of disease types, refer to the outpatient chronic disease type code and disease type name in the national medical security information business coding standard.
    This pilot disease type includes hypertension, diabetes, malignant tumor outpatient radiotherapy and chemotherapy (corresponding to the business coding standard Outpatient treatment for malignant tumors in China), uremic dialysis (corresponding to dialysis in the business coding standard), anti-rejection treatment after organ transplantation (corresponding to the anti-rejection treatment of kidney transplantation, bone marrow transplantation anti-rejection treatment in the business coding standard, Anti-rejection therapy for heart transplantation, anti-rejection therapy for liver transplantation, anti-rejection therapy for lung transplantation, and anti-rejection therapy for liver and kidney transplantation) and other outpatient chronic diseases
    .
     
    The notice clearly stated that when the outpatient chronic special disease related treatment costs are directly settled across provinces, the national unified outpatient chronic special disease disease code and disease name shall be used to temporarily settle the payment method according to the project, and the payment scope and relevant regulations of the medical place shall be implemented ( basic medical insurance drugs , medical services and medical supplies, and other pay range), the implementation of the health care insurance fund from the pay standard , pay the proportion of the relevant provisions, the maximum payment and so on
    .
     
    In addition, when designated medical institutions provide cross-provincial direct settlement services for insured persons who are eligible for outpatient chronic and special diseases, they should treat specific diseases, use drugs rationally, and separately settle the outpatient chronic and special disease-related treatment costs
    .
    After dividing the cost of each item according to the local payment scope and regulations, the medical place will transmit it to the insured place together with the outpatient chronic disease code of the insured person
    .
    The insured place calculates the personal burden of the insured person and the amount paid by the various medical insurance funds according to the regulations, and returns the results to the designated medical institution in the place of treatment
    .
      Xinhua News Agency, Beijing, September 15 (Reporter Peng Yunjia) In order to further solve the "difficult and sorrowful" problem encountered by the people in trans-provincial treatment and settlement, the National Medical Insurance Bureau has made it clear that by the end of 2021, each province (autonomous region, municipality) and Xinjiang production and construction Corps select at least one co-ordinating carry out inter-provincial direct treatment costs related to clearing pilot outpatient slow special disease, we can offer high blood pressure , diabetes, malignant tumor outpatient chemotherapy, uremia, dialysis, organ transplantation anti-rejection therapy after five The treatment costs related to chronic diseases in outpatient clinics are directly settled across provinces
    .
     
      According to the "Notice on Implementing the Pilot Work for Direct Settlement of Outpatient Chronic and Special Diseases Related Treatment Expenses" issued by the National Medical Insurance Administration and the Ministry of Finance, the pilot population has completed the above five outpatient chronic and special disease treatment qualification certifications in the insured area.
    And in accordance with the regulations of the place of insured, the personnel who have gone through the procedures for medical records in different places across provinces
    .
     
      In order to be compatible with the differences in the scope of disease types, refer to the outpatient chronic disease type code and disease type name in the national medical security information business coding standard.
    This pilot disease type includes hypertension, diabetes, malignant tumor outpatient radiotherapy and chemotherapy (corresponding to the business coding standard Outpatient treatment for malignant tumors in China), uremic dialysis (corresponding to dialysis in the business coding standard), anti-rejection treatment after organ transplantation (corresponding to the anti-rejection treatment of kidney transplantation, bone marrow transplantation anti-rejection treatment in the business coding standard, Anti-rejection therapy for heart transplantation, anti-rejection therapy for liver transplantation, anti-rejection therapy for lung transplantation, and anti-rejection therapy for liver and kidney transplantation) and other outpatient chronic diseases
    .
     
      The notice clearly stated that when the outpatient chronic special disease related treatment costs are directly settled across provinces, the national unified outpatient chronic special disease disease code and disease name shall be used to temporarily settle the payment method according to the project, and the payment scope and relevant regulations of the medical place shall be implemented ( basic medical insurance drugs , medical services and medical supplies, and other pay range), the implementation of the health care insurance fund from the pay standard , pay the proportion of the relevant provisions, the maximum payment and so on
    .
     
      In addition, when designated medical institutions provide cross-provincial direct settlement services for insured persons who are eligible for outpatient chronic and special diseases, they should treat specific diseases, use drugs rationally, and separately settle the outpatient chronic and special disease-related treatment costs
    .
    After dividing the cost of each item according to the local payment scope and regulations, the medical place will transmit it to the insured place together with the outpatient chronic disease code of the insured person
    .
    The insured place calculates the personal burden of the insured person and the amount paid by the various medical insurance funds according to the regulations, and returns the results to the designated medical institution in the place of treatment
    .
      Xinhua News Agency, Beijing, September 15 (Reporter Peng Yunjia) In order to further solve the "difficult and sorrowful" problem encountered by the people in trans-provincial treatment and settlement, the National Medical Insurance Bureau has made it clear that by the end of 2021, each province (autonomous region, municipality) and Xinjiang production and construction Corps select at least one co-ordinating carry out inter-provincial direct treatment costs related to clearing pilot outpatient slow special disease, we can offer high blood pressure , diabetes, malignant tumor outpatient chemotherapy, uremia, dialysis, organ transplantation anti-rejection therapy after five The treatment costs related to chronic diseases in outpatient clinics are directly settled across provinces
    .
      Hypertension hypertension hypertension tumor tumor tumor
     
      According to the "Notice on Implementing the Pilot Work for Direct Settlement of Outpatient Chronic and Special Diseases Related Treatment Expenses" issued by the National Medical Insurance Administration and the Ministry of Finance, the pilot population has completed the above five outpatient chronic and special disease treatment qualification certifications in the insured area.
    And in accordance with the regulations of the place of insured, the personnel who have gone through the procedures for medical records in different places across provinces
    .
     
      In order to be compatible with the differences in the scope of disease types, refer to the outpatient chronic disease type code and disease type name in the national medical security information business coding standard.
    This pilot disease type includes hypertension, diabetes, malignant tumor outpatient radiotherapy and chemotherapy (corresponding to the business coding standard Outpatient treatment for malignant tumors in China), uremic dialysis (corresponding to dialysis in the business coding standard), anti-rejection treatment after organ transplantation (corresponding to the anti-rejection treatment of kidney transplantation, bone marrow transplantation anti-rejection treatment in the business coding standard, Anti-rejection therapy for heart transplantation, anti-rejection therapy for liver transplantation, anti-rejection therapy for lung transplantation, and anti-rejection therapy for liver and kidney transplantation) and other outpatient chronic diseases
    .
     
      The notice clearly stated that when the outpatient chronic special disease related treatment costs are directly settled across provinces, the national unified outpatient chronic special disease disease code and disease name shall be used to temporarily settle the payment method according to the project, and the payment scope and relevant regulations of the medical place shall be implemented ( basic medical insurance drugs , medical services and medical supplies, and other pay range), the implementation of the health care insurance fund from the pay standard , pay the proportion of the relevant provisions, the maximum payment and so on
    .
    Drugs Drugs Drugs Standard Standard Standard
     
      In addition, when designated medical institutions provide cross-provincial direct settlement services for insured persons who are eligible for outpatient chronic and special diseases, they should treat specific diseases, use drugs rationally, and separately settle the outpatient chronic and special disease-related treatment costs
    .
    After dividing the cost of each item according to the local payment scope and regulations, the medical place will transmit it to the insured place together with the outpatient chronic disease code of the insured person
    .
    The insured place calculates the personal burden of the insured person and the amount paid by the various medical insurance funds according to the regulations, and returns the results to the designated medical institution in the place of treatment
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.